NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
GRAYSPACE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GRAYSPACE THERAPEUTICS
ST13
US500000088873267Class
5
Filing
88873267
Registration
8140236
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
82
Latest update
02/17/2026
Trademark type
Word
Nice classes
5
Filing date
04/15/2020
Registration date
02/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Saskatoon, SK, CA
Examiner
LOVELACE, JAMES B
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Med-Life Discoveries GP Inc.
Representatives
Roger H. Bora Thompson Hine LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Synthesized plasmalogen-based therapeutic compounds for the treatment of Alzheimer's DiseaseParkinson's Disease and other neurological indications that have a plasmalogen deficiency
Publications
History of USPTO decisions and trademark events.
82 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2025
PUBO
PUBLISHED FOR OPPOSITION
12/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2025
GNRT
NON-FINAL ACTION E-MAILED
10/08/2025
CNRT
NON-FINAL ACTION WRITTEN
10/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/24/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/28/2025
GNSL
LETTER OF SUSPENSION E-MAILED
04/28/2025
CNSL
SUSPENSION LETTER WRITTEN
04/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/18/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/29/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/29/2025
CNSI
SUSPENSION INQUIRY WRITTEN
01/29/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/16/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/29/2024
GNSL
LETTER OF SUSPENSION E-MAILED
02/29/2024
CNSL
SUSPENSION LETTER WRITTEN
02/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/29/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/28/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/22/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/22/2024
CNSI
SUSPENSION INQUIRY WRITTEN
02/22/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/16/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/15/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/15/2023
CNSL
SUSPENSION LETTER WRITTEN
08/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/14/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/19/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/19/2023
CNSI
SUSPENSION INQUIRY WRITTEN
07/19/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/18/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/15/2022
GNSL
LETTER OF SUSPENSION E-MAILED
12/15/2022
CNSL
SUSPENSION LETTER WRITTEN
12/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/13/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/23/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/23/2022
CNSI
SUSPENSION INQUIRY WRITTEN
11/23/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/18/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/07/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/07/2022
CNSL
SUSPENSION LETTER WRITTEN
04/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2022
ALIE
ASSIGNED TO LIE
04/01/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/30/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/05/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/05/2021
CNSI
SUSPENSION INQUIRY WRITTEN
10/05/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/04/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/19/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/19/2021
CNSL
SUSPENSION LETTER WRITTEN
03/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2021
ALIE
ASSIGNED TO LIE
03/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
09/16/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
09/16/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/07/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/07/2020
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
07/07/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
07/07/2020
DOCK
ASSIGNED TO EXAMINER
07/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2020
NWAP
NEW APPLICATION ENTERED
04/18/2020
Continuous trademark protection
Get notified about every new filing that threatens GRAYSPACE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.